Medical News

RSS

FDA approves Merck's Isentress to treat HIV-1 infection in children, adolescents

Isentress (raltegravir) was approved today by the U.S. Food and Drug Administration for use with other antiretroviral drugs for the treatment of HIV-1 infection for children and adolescents ages 2-18.

22 Dec 2011

Kansas officials revise plans for reorganizing social services; Wis. study finds problems in Medicaid oversight

Kansas lawmakers grilled state officials about Gov. Sam Brownback's plans to streamline the state bureaucracy. In Wis., the legislative analysis found that private contractors are taking on an increasing share of the work of administering Medicaid programs.

22 Dec 2011

ASGE honors 27 endoscopy units with 'Certificate of Recognition'

The American Society for Gastrointestinal Endoscopy (ASGE) has recognized 27 endoscopy units as part of its program specifically dedicated to promoting quality in endoscopy, in all settings where it is practiced in the United States.

22 Dec 2011

ACTF, Merck announce new HIV initiatives

Today, Merck, known as MSD outside the United States and Canada, and the ADAP Crisis Task Force (ACTF) announced a number of new initiatives to help struggling state AIDS Drug Assistance Programs (ADAPs) continue to provide access to medicines to people living with HIV.

22 Dec 2011

Impax submits IPX066 NDA to FDA for treatment of Parkinson's

Impax Pharmaceuticals, the branded products division of Impax Laboratories, Inc. today announced the submission of Impax's New Drug Application (NDA) for IPX066 to the U.S. Food and Drug Administration (FDA) for the treatment of idiopathic Parkinson's disease (PD). IPX066 is a patented extended release capsule formulation of carbidopa-levodopa.

22 Dec 2011

Leishmania parasite develops combined resistance against drug, human immune system

Scientists of the Institute of Tropical Medicine (ITG) discovered a parasite that not only had developed resistance against a common medicine, but at the same time had become better in withstanding the human immune system.

22 Dec 2011

Five weight loss tips for the New Year

With the new year right around the corner, many will be thinking about their New Year's resolution. One of the most popular - losing weight - can also be one of the most difficult to keep. But researchers at Temple's Center for Obesity Research and Education (CORE) work year-round to study the treatment and prevention of obesity.

22 Dec 2011

People with smaller regions of brain's cortex more likely to develop early Alzheimer's

New research suggests that, in people who don't currently have memory problems, those with smaller regions of the brain's cortex may be more likely to develop symptoms consistent with very early Alzheimer's disease.

22 Dec 2011

Researchers discover how normal cells in tumors can drive cancer growth

•A new study published in the journal Nature Cell Biology has discovered how normal cells in tumors can fuel tumor growth.

22 Dec 2011

Agilent acquires BioSystem Development business

Agilent Technologies Inc. today announced it has completed the acquisition of the BioSystem Development business. BioSystem Development is a privately held company that develops and manufactures the AssayMAP Microchromatography platform to meet the analytical needs of the life sciences industry.

22 Dec 2011

Roundup: Health coverage drops again in Fla.; Calif. wrestles with issue of violence in mental hospitals

Enrollment in commercial health insurance is continuing to decline in Florida. An annual market report adopted Tuesday by the Florida Health Care Insurance Advisory Board shows enrollment dropped by 4.3 percent during 2010. That's the fifth straight year it's gone down.

22 Dec 2011

Reva Medical commences its first clincial trial

Reva Medical, a medical device company, has today commenced the very first clinical trial of its ReZolve™ bioresorbable coronary stent. A patient in Brazil was implanted with the device overnight, which flags an exciting chapter for Reva Medical.

21 Dec 2011

New pharma title from iSmithers ‘Update on Polymers for Ocular Drug Delivery’

The eye is the most easily accessible site for topical administration of a medication. Drugs are commonly applied to the eye for localised action on the surface or in the interior of the eye. A major problem in ocular therapeutics is the attainment of an optimal drug concentration at the site of action.

21 Dec 2011

Sunless tanners could reduce sunbathing time: Study

Sunless tanners like creams and sprays that fake a tan may reduce their sunbathing time and tanning bed use, according to a new study. “Using the sunless tanners can change tanning behaviors,” says researcher Suephy C. Chen, associate professor of dermatology at Emory University School of Medicine. “People who used the sunless tanners decreased the number of times they laid out or went to tanning booths.”

21 Dec 2011

Malaria vaccine shows early success

An experimental vaccine for malaria has been developed by British scientists. It has shown early potential to neutralize many, perhaps all, strains of the deadliest malaria parasite.

21 Dec 2011

Breastfeeding should continue until 12 months urge experts

According to a report by the Australian Institute of Health and Welfare women who are breastfeeding are steadily becoming a smaller number. The report notes that only 40 per cent of mothers still exclusively breastfeed their babies at three months and 15 per cent of mothers are still breastfeeding at five months. This is despite health guidelines that recommend breastfeeding for the first six months.

21 Dec 2011

Virus with potential for bioterrorism created – Experts worried

Two major scientific journals are debating on whether to publish details of a man-made mutant flu virus that could kill billions, after a US government's science advisory committee advised them to withhold key details.

21 Dec 2011

Fear of cancer spurs breast implant recall

There are concerns regarding breast implants and the association with cancer. UP to 30,000 French women and perhaps tens of thousands more around the world may need to have defective breast implants removed after several suspicious cancer cases. The final decision on recall of the implants, produced by the Poly Implant Prothese (PIP) company will be made by the end of the week, after a report from France's National Cancer Institute on December 23.

21 Dec 2011

Neurotechnology announces availability of VeriLook Surveillance 2.0

Neurotechnology, a provider of high-precision biometric identification technologies, today announced the availability of VeriLook Surveillance 2.0, a software development kit (SDK) for biometric face identification using live video streams from single or multiple high-resolution digital surveillance cameras.

21 Dec 2011

First Edition: December 21, 2011

In the past year, Medicare politics and policies have grabbed headlines, with politicians from both sides of the aisle talking about "saving Medicare," "protecting beneficiaries," "improving quality of care," and "curbing fraud and abuse."

21 Dec 2011